Lucid Diagnostics Inc
LUCD
Get informed when a big investor buys or sells
+ FollowMarket Cap$189.13M
Close$
$2.12
122.4% upside
Current Fair Value
122.4% upsideUndervalued by 122.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $189.13 Million |
|---|---|
| Enterprise Value | $180.64 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.69 |
| Beta | 1.08 |
| Outstanding Shares | 183,124,412 |
Return
| Return on Equity | -740824.12% |
|---|---|
| Return on Assets | -207851.52% |
| Return on Invested Capital | -91275.66% |
Valuation & Multiples
| P/E Ratio | -2.13 |
|---|---|
| PEG | -1.3 |
| Price to Sales | 0.03 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.03 |
| Enterprise Value to EBIT | -0.02 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 2.28 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$-0.06
Average shareholder expectationRevenue Estimate
$1.48 M
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.04
Average shareholder expectationRevenue Estimate
$1.63 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 34.94%▲ 3.37% |
|---|---|
| Total Invested | $40.96M▲ 16.62% |
| Investors Holding | 103▲ 14.00% |
ESG Score
No data